Market Tracker

12/26 6:02pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.03
Data as of Dec 26
 +0.01 / +0.98%
Today’s Change
0.78
Today|||52-Week Range
1.83
-11.21%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.02
Today’s open1.02
Day’s range1.02 - 1.05
Volume137,542
Average volume (3 months)243,126
Market cap$45.5M
Dividend yield--
Data as of 3:59pm ET, 12/26/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio1.6
Price/Sales1.47
Price/Book8.64

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...+0.01+3.14%
APRIApricus Biosciences ...+0.02+1.98%
AVEOAveo Pharmaceuticals...+0.07+8.54%
CTRVContraVir Pharmaceut...-0.02-0.95%
Data as of 4:01pm ET, 12/26/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts